LEXINGTON, Mass., July 30, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming virtual Canaccord Genuity Annual Growth Conference.
Management is scheduled to present Thursday, August 13, 2020 at 9:30am ET. Interested parties may access a live and recorded webcast of the presentation on the “Investors” section of the Company’s website at www.t2biosystems.com. Media Contact:
Gina Kent, Vault Communications
[email protected]  
610-455-2763Investor Contact:
Philip Trip Taylor, Gilmartin Group
[email protected]
415-937-5406

Bay Street News